Woodside Biomedical to Expand Market Reach Through ChainDrugStore.net


ALEXANDRIA, Va., May 15, 2001 (PRIMEZONE) -- ChainDrugStore.net announced today that Woodside Biomedical, Inc., will expand its market reach for the ReliefBand(r) device through ChainDrugStore.net.

ChainDrugStore.net is the new online infomediary for the $400 billion retail drug store industry. Over 95 retailers representing over $300 billion in annual sales in 25,600 stores as well as suppliers including Bristol-Myers Squibb, GlaxoSmithKline, Procter & Gamble, Rexall Sundown, PureTek and TheraSense have signed on since December 2000.

Woodside Biomedical, Inc., develops, manufactures and markets therapeutic medical devices for the treatment of nausea and vomiting. The ReliefBand device, worn like a sports watch, is the only drug-free remedy to have received FDA clearance, without a prescription, for the treatment of nausea and vomiting due to motion sickness. Other versions are available, by prescription, for the treatment of nausea and vomiting of pregnancy (morning sickness), chemotherapy and as an adjunct to other anti-emetics for post-operative nausea.

"ChainDrugStore.net is the Web-based sales and marketing tool that will allow Woodside Biomedical to implement our go-to-market strategy for the ReliefBand device more efficiently and cost-effectively," stated Greg Gruzdowich, President and Chief Executive of the Carlsbad, California-based company. "ChainDrugStore.net evens the playing field for smaller manufacturers such as Woodside. And ChainDrugStore.net staff is working with us every step of the way as we develop product-related marketing and merchandising information and instantly transmit it to retail chain drug stores representing over $300 billion in annual sales."

"Our commitment to Woodside and other suppliers extends beyond providing a comprehensive Web-based marketing solution," stated ChainDrugStore.net's President and CEO Brad Mitchell. "ChainDrugStore.net offers exceptional customer service, technical support and training as well as strategic consulting on go-to-market strategies."

For more information on how ChainDrugStore.net can help develop business, contact Vice President of Customer Development Doug Cross at (703) 837-8323 or Dcross@chaindrugstore.net; Vice President of Pharmacy Matt Erick at (703) 837-8322 or Merick@chaindrugstore.net; or Vice President of Consulting Services Lee Rudibaugh at (703) 837-8324 or Lrudibaugh@chaindrugstore.net.

About ChainDrugStore.net

ChainDrugStore.net, based in Alexandria, Va., is the infomediary for the $400 billion chain drug store industry. It is a Web-based tool that reduces the cost of communicating between suppliers and retailers. ChainDrugStore.net is a wholly-owned, subsidiary of the National Association of Chain Drug Stores.

About Woodside Biomedical

Woodside Biomedical Inc., based in Carlsbad, Calif., develops, manufactures and markets therapeutic medical devices for the treatment of nausea and vomiting. Additional information about the company and the ReliefBand device can be obtained from Woodside's Web site at: www.reliefband.com

About ReliefBand

The ReliefBand device uses gentle electrical signals to stimulate nerves in the wrist. This wrist stimulation, according to the theory of action proposed by some researches, causes natural nerve impulses to travel up the arm into the spinal cord and brain. It is believed that these natural nerve impulses interfere with the nausea messages going to the stomach. The ReliefBand has received FDA clearance for OTC use to treat symptoms of motion sickness and for prescription use to treat nausea and vomiting associated with morning sickness, chemotherapy as well as post-operative nausea. ReliefBand is a registered trademark of Woodside Biomedical, Inc.

-0-
CONTACT: ChainDrugStore.net, Alexandria
         Rae Nelson
         (703) 837-8333
         Rnelson@chaindrugstore.net